Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001424422-16-000024
Filing Date
2016-06-14
Accepted
2016-06-14 18:49:52
Documents
1
Period of Report
2016-06-13

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 4160
  Complete submission text file 0001424422-16-000024.txt   5561
Mailing Address 1098 HAMILTON COURT MENLO PARK CA 94025
Business Address 1098 HAMILTON COURT MENLO PARK CA 94025 650-889-5020
BioPharmX Corp (Issuer) CIK: 0001504167 (see all company filings)

EIN.: 593843182 | State of Incorp.: DE | Fiscal Year End: 0131
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1098 HAMILTON COURT MENLO PARK CA 94025
Business Address
Morlock Stephen (Reporting) CIK: 0001637670 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37411 | Film No.: 161714117